{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:19:10Z","timestamp":1783163950033,"version":"3.54.6"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Karadeniz Technical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11544-z","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T10:25:50Z","timestamp":1775989550000},"page":"6389-6402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synthesis of new sulfonamides from sulfamethizole: in vitro antitubercular and antimicrobial activities supported by molecular docking, molecular dynamics, and ADME studies"],"prefix":"10.1007","volume":"30","author":[{"given":"Sevda","family":"T\u00fcrk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"K\u0131r\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"\u00c7ift\u00e7i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130smail","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgi","family":"Karaku\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"\u015eatana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,12]]},"reference":[{"key":"11544_CR1","doi-asserted-by":"publisher","first-page":"107667","DOI":"10.1016\/j.bioorg.2024.107667","volume":"151","author":"S Indalkar","year":"2024","unstructured":"Indalkar S, Sahoo DK, Bhange DS, Waghmode M, Shekh S, Gaikwad LD, Gadave KM (2024) Pyrimidine-based sulfonamides and acetamides as potent antimicrobial agents: synthesis, computational studies, and biological assessment. Bioorg Chem 151:107667. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107667","journal-title":"Bioorg Chem"},{"key":"11544_CR2","doi-asserted-by":"publisher","first-page":"103265","DOI":"10.1016\/j.cis.2024.103265","volume":"332","author":"Z Guo","year":"2024","unstructured":"Guo Z, Jiang H, Song A, Liu X, Wang X (2024) Progress and challenges in bacterial infection theranostics based on functional metal nanoparticles. Adv Colloid Interface Sci 332:103265. https:\/\/doi.org\/10.1016\/j.cis.2024.103265","journal-title":"Adv Colloid Interface Sci"},{"issue":"6","key":"11544_CR3","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S2213-2600(24)00028-6","volume":"12","author":"AK Coussens","year":"2024","unstructured":"Coussens AK, Zaidi SMA, Alwood BW, Dewan PK, Gray G, Kohli M, Kredo T, Marais BJ, Marks GB, Martinez L, Ruhwald M, Scriba TJ, Seddon JA, Tisile P, Warner DF, Wilkinson RJ, Esmail H, Houben RMGJ (2024) Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise. Lancet Respir Med 12(6):484\u2013498. https:\/\/doi.org\/10.1016\/S2213-2600(24)00028-6","journal-title":"Lancet Respir Med"},{"key":"11544_CR4","doi-asserted-by":"publisher","first-page":"137234","DOI":"10.1016\/j.molstruc.2023.137234","volume":"1300","author":"TC Amaral","year":"2024","unstructured":"Amaral TC, Glanzmann N, Silvab AD, Pereirac GM, Corbic PP, Canales CSC, Pavand FR, Oliveira KAD, Cuina A (2024) Synthesis, spectroscopic and structural characterizations and in vitro antimycobacterial activity of silver(I) complexes with sulfapyridine (SPY) and sulfamerazine (SM). J Mol Struct 1300:137234. https:\/\/doi.org\/10.1016\/j.molstruc.2023.137234","journal-title":"J Mol Struct"},{"issue":"9","key":"11544_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/10426507.2023.2196079","volume":"198","author":"MJ Hearn","year":"2023","unstructured":"Hearn MJ, Pugh CD, Cynamon MH (2023) Synthesis of functionalized sulfonamides as antitubercular agents, Phosphorus, Sulfur, Silicon Relat. Elem 198(9):733\u2013751. https:\/\/doi.org\/10.1080\/10426507.2023.2196079","journal-title":"Elem"},{"key":"11544_CR6","doi-asserted-by":"publisher","first-page":"139358","DOI":"10.1016\/j.molstruc.2024.139358","volume":"1319","author":"KK Vinay","year":"2025","unstructured":"Vinay KK, Yadav DB, Shivakumar N, Udayakumar D, Nagaraja O, Chethan K (2025) Synthesis, computational and UV\u2013Vis absorption studies of novel sulfathiazole azo sulfonamides acting as potent antitubercular agents. J Mol Struct 1319:139358. https:\/\/doi.org\/10.1016\/j.molstruc.2024.139358","journal-title":"J Mol Struct"},{"key":"11544_CR7","doi-asserted-by":"publisher","first-page":"107409","DOI":"10.1016\/j.bioorg.2024.107409","volume":"147","author":"KA Elsayad","year":"2024","unstructured":"Elsayad KA, Elmasry GF, Mahmoud ST, Awadallah FM (2024) Sulfonamides as anticancer agents: a brief review on sulfonamide derivatives as inhibitors of various proteins overexpressed in cancer. Bioorg Chem 147:107409. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107409","journal-title":"Bioorg Chem"},{"key":"11544_CR8","doi-asserted-by":"publisher","first-page":"102025","DOI":"10.1016\/j.jsps.2024.102025","volume":"32","author":"NM Abdelazeem","year":"2024","unstructured":"Abdelazeem NM, Aboulthana WM, Hassan AS, Almehizia AA, Naglah AM, Alkahtani HM (2024) Synthesis, in silico ADMET prediction analysis, and pharmacological evaluation of sulfonamide derivatives tethered with pyrazole or pyridine as anti-diabetic and anti-alzheimer\u2019s agents. Saudi Pharm J 32:102025. https:\/\/doi.org\/10.1016\/j.jsps.2024.102025","journal-title":"Saudi Pharm J"},{"key":"11544_CR9","doi-asserted-by":"publisher","first-page":"23257","DOI":"10.1039\/D4RA04548C","volume":"14","author":"GI Buravchenko","year":"2024","unstructured":"Buravchenko GI, Scherbakov AM, Krymov SK, Salnikova DI, Zatonsky GV, Schols D, Vullo D, Supuran CT, Shchekotikhin AE (2024) Synthesis and evaluation of sulfonamide derivatives of quinoxaline 1,4-dioxides as carbonic anhydrase inhibitors. RSC Adv 14:23257. https:\/\/doi.org\/10.1039\/D4RA04548C","journal-title":"RSC Adv"},{"issue":"3","key":"11544_CR10","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1128\/aac.47.3.1002-1009.2003","volume":"47","author":"NB Kerrn","year":"2003","unstructured":"Kerrn NB, Moller NF, Espersen F (2003) Effects of sulfamethizole and amdinocillin against Escherichia coli strains (with various susceptibilities) in an ascending urinary tract infection mouse model. Antimicrob Agents Chemother 47(3):1002\u20131009. https:\/\/doi.org\/10.1128\/aac.47.3.1002-1009.2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"11544_CR11","doi-asserted-by":"publisher","first-page":"10733","DOI":"10.20964\/2018.11.33","volume":"13","author":"V Pehlivan","year":"2018","unstructured":"Pehlivan V, Bicer E, Bekiroglu YG, Dege N (2018) Electrochemical and spectroscopic studies on the interaction modes of calf thymus DNA with antibacterial schiff bases obtained from substituted salicylaldehydes and sulfamethizole. Int J Electrochem Sci 13(11):10733\u201310750. https:\/\/doi.org\/10.20964\/2018.11.33","journal-title":"Int J Electrochem Sci"},{"issue":"1","key":"11544_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.12991\/marupj.259885","volume":"21","author":"S T\u00fcrk","year":"2017","unstructured":"T\u00fcrk S, Tok F, Celik H, Karakus S, Nadaro\u011flu H, Kocyi\u011fit-Kaymakc\u0131o\u011flu B, Kucuko\u011flu K (2017) Some N-(5-methyl-1,3,4-thiadiazol-2-yl)-4-(3-substituted)ureido\/thioureidobenzenesulfonamides as carbonic anhydrase I and II inhibitors. Marmara Pharm J 21(1):89\u201395. https:\/\/doi.org\/10.12991\/marupj.259885","journal-title":"Marmara Pharm J"},{"issue":"8","key":"11544_CR13","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1080\/10426507.2018.1452924","volume":"193","author":"S Karaku\u015f","year":"2018","unstructured":"Karaku\u015f S, Tok F, T\u00fcrk S, Salva E, Tatar G, Task\u0131n-Tok T, Kocyigit-Kaymakcioglu B (2018) Synthesis, anticancer activity and ADMET studies of N-(5-methyl-1,3,4-thiadiazol-2-yl)-4-[(3-subsituted)ureido\/thioureido]benzenesulfonamide derivatives, Phosphorus, Sulfur Silicon Relat. Elem 193(8):528\u2013534. https:\/\/doi.org\/10.1080\/10426507.2018.1452924","journal-title":"Elem"},{"key":"11544_CR14","doi-asserted-by":"publisher","first-page":"137266","DOI":"10.1016\/j.molstruc.2023.137266","volume":"1300","author":"H Jiang","year":"2024","unstructured":"Jiang H, Lan N, Ma W, Zhang Z, Zhao Z, Hu Y, Su Y, Huang Y, Wang Y, Xu D, Liu K (2024) Synthesis and evaluation of the antitumor activity of 2-amino-4-tetrahydroindazole-substituted benzamide derivatives as HSP90 inhibitors. J Mol Struct 1300:137266. https:\/\/doi.org\/10.1016\/j.molstruc.2023.137266","journal-title":"J Mol Struct"},{"key":"11544_CR15","doi-asserted-by":"publisher","first-page":"107450","DOI":"10.1016\/j.bioorg.2024.107450","volume":"148","author":"X Zhao","year":"2024","unstructured":"Zhao X, Wang R, Zhang F, Luo F, Zhong T, Linghu A, Xiong L, Yang H, Fan Y (2024) Synthesis and antitumor activities of novel 3-(6-aminopyridin-3-yl)benzamide derivatives: inducing cell cycle arrest and apoptosis via AURKB transcription inhibition. Bioorg Chem 148:107450. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107450","journal-title":"Bioorg Chem"},{"key":"11544_CR16","doi-asserted-by":"publisher","first-page":"106322","DOI":"10.1016\/j.bioorg.2022.106322","volume":"131","author":"B Kilic","year":"2023","unstructured":"Kilic B, Bardakkaya M, Il\u0131kc\u0131 Sagkan R, Aksakal F, Shakila S, Dogruer DS (2023) New thiourea and benzamide derivatives of 2-aminothiazole as multi-target agents against alzheimer\u2019s disease: design, synthesis, and biological evaluation. Bioorg Chem 131:106322. https:\/\/doi.org\/10.1016\/j.bioorg.2022.106322","journal-title":"Bioorg Chem"},{"key":"11544_CR17","doi-asserted-by":"publisher","first-page":"134103","DOI":"10.1016\/j.molstruc.2022.134103","volume":"1272","author":"Z Xie","year":"2023","unstructured":"Xie Z, Liang Z, Huang Y, Shi K, Zang N, Wang M, Liang T, Wei W (2023) Discovery and biological evaluation of 2-((3-phenylisoxazol-5-yl)methoxy)benzamide derivatives as potent nucleocapsid inhibitors. J Mol Struct 1272:134103. https:\/\/doi.org\/10.1016\/j.molstruc.2022.134103","journal-title":"J Mol Struct"},{"key":"11544_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bbrc.2016.09.041","volume":"479","author":"SRM Ibrahim","year":"2016","unstructured":"Ibrahim SRM, Elkhayat ES, Mohamed GAA, Fat\u2019hi SM, Ross SA (2016) Fusarithioamide A, a new antimicrobial and cytotoxic benzamide derivative from the endophytic fungus Fusarium Chlamydosporium, Biochem. Biophys Res Commun 479:211\u2013216. https:\/\/doi.org\/10.1016\/j.bbrc.2016.09.041","journal-title":"Biophys Res Commun"},{"key":"11544_CR19","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.bioorg.2019.01.014","volume":"85","author":"MK Samad","year":"2019","unstructured":"Samad MK, Hawaiz FE (2019) Synthesis, characterization, antioxidant power and acute toxicity of some new azo-benzamide and azo-imidazolone derivatives with in vivo and in vitro antimicrobial evaluation. Bioorg Chem 85:431\u2013444. https:\/\/doi.org\/10.1016\/j.bioorg.2019.01.014","journal-title":"Bioorg Chem"},{"key":"11544_CR20","doi-asserted-by":"publisher","first-page":"101082","DOI":"10.1016\/j.jics.2023.101082","volume":"100","author":"H Kaur","year":"2023","unstructured":"Kaur H, Devi B, Alajangi HK, Kumar R, Singh G, Barnwal RP, Yadav AK (2023) Design, synthesis, biological evaluation and in silico studies of N-(pyridin-2-yl)-benzamides derivatives as quorum sensing inhibitors. J Indian Chem Soc 100:101082. https:\/\/doi.org\/10.1016\/j.jics.2023.101082","journal-title":"J Indian Chem Soc"},{"key":"11544_CR21","doi-asserted-by":"publisher","first-page":"137620","DOI":"10.1016\/j.molstruc.2024.137620","volume":"1303","author":"S Kamalov","year":"2024","unstructured":"Kamalov S, Babaev B, Ibragimov A, Eshimbetov A, Ashurov J, Normamatov A, Tilyakov Z, Usmanov S, Tashpulatov J, Ibragimov B (2024) Antimicrobial activity enhancement and acute toxicity lowering of benzamide through preparation of metal complexes. J Mol Struct 1303:137620. https:\/\/doi.org\/10.1016\/j.molstruc.2024.137620","journal-title":"J Mol Struct"},{"key":"11544_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejmech.2015.10.035","volume":"106","author":"J Ramprasad","year":"2015","unstructured":"Ramprasad J, Nayak N, Dalimba U (2015) Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents. Eur J Med Chem 106:75\u201384. https:\/\/doi.org\/10.1016\/j.ejmech.2015.10.035","journal-title":"Eur J Med Chem"},{"key":"11544_CR23","doi-asserted-by":"publisher","first-page":"136011","DOI":"10.1016\/j.molstruc.2023.136011","volume":"1291","author":"M Fan","year":"2023","unstructured":"Fan M, Feng Q, Yang W, Peng Z, Wang G (2023) Thiazole-benzamide derivatives as \u03b1-glucosidase inhibitors: synthesis, kinetics study, molecular docking, and in vivo evaluation. J Mol Struct 1291:136011. https:\/\/doi.org\/10.1016\/j.molstruc.2023.136011","journal-title":"J Mol Struct"},{"issue":"3","key":"11544_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.26650\/IstanbulJPharm.2018.18007","volume":"48","author":"S Turk","year":"2018","unstructured":"Turk S, Turan K, Ulusoy S, Karaku\u015f S, Bo\u015fgelmez-T\u0131naz G (2018) Synthesis and biological activity studies on amide derivatives. Istanbul J Pharm 48(3):76\u201381. https:\/\/doi.org\/10.26650\/IstanbulJPharm.2018.18007","journal-title":"Istanbul J Pharm"},{"key":"11544_CR25","unstructured":"CLSI (2018) Susceptibility testing of Mycobacteria, Nocardia spp., and other aerobic actinomycetes. 3rd ed. CLSI standard M24. Wayne, PA: Clinical and Laboratory Standards Institute"},{"key":"11544_CR26","unstructured":"CLSI (2018) Performance standards for susceptibility testing of Mycobacteria, Nocardia spp., and other aerobic actinomycetes. 1st ed. CLSI supplement M62. Wayne, PA: Clinical and Laboratory Standards Institute"},{"key":"11544_CR27","volume-title":"Optimized broth microdilution plate methodology for drug susceptibility testing of Mycobacterium tuberculosis complex","author":"World Health Organization","year":"2022","unstructured":"World Health Organization (2022) Optimized broth microdilution plate methodology for drug susceptibility testing of Mycobacterium tuberculosis complex. World Health Organization, Geneva"},{"key":"11544_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1590\/S1517-83822008000100004","volume":"39","author":"KO Sanchotene","year":"2008","unstructured":"Sanchotene KO, von Groll A, Ramos D, Scholante AB, Honscha G, Valen\u00e7a M, Scaini CJ, Da PEA, Silva (2008) Comparative evaluation of the nitrate reductase assay and the resazurin microtitre assay for drug susceptibility testing of mycobacterium tuberculosis against first line anti-tuberculosis drugs. Brazil J Microbiol 39:16\u201320. https:\/\/doi.org\/10.1590\/S1517-83822008000100004","journal-title":"Brazil J Microbiol"},{"key":"11544_CR29","volume-title":"Reference method for broth dilution antifungal susceptibility testing filamentous fungi; Approved Standard Second Edition M38-A2","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute (2008) Reference method for broth dilution antifungal susceptibility testing filamentous fungi; approved standard second edition M38-A2. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA"},{"key":"11544_CR30","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard- Third Edition M27-A3","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard- third edition M27-A3. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA"},{"key":"11544_CR31","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard- Third Edition M27-S3","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard- third edition M27-S3. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA"},{"key":"11544_CR32","unstructured":"Clinical and Laboratory Standards Institute (2020) Performance standards for antifungal susceptibility testing of yeasts; second edition M60- ED2:2020. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA"},{"key":"11544_CR33","unstructured":"CLSI M100-ED34 (2024) 2024 performance standards for antimicrobial susceptibility testing, 34th edition http:\/\/em100.edaptivedocs.net\/dashboard.aspx"},{"key":"11544_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s44259-024-00051-6","volume":"2","author":"N Kade\u0159\u00e1bkov\u00e1","year":"2024","unstructured":"Kade\u0159\u00e1bkov\u00e1 N, Mahmood AJS, Mavridou DAI (2024) Antibiotic susceptibility testing using minimum inhibitory concentration (MIC) assays. npj Antimicrob Resist 2:37. https:\/\/doi.org\/10.1038\/s44259-024-00051-6","journal-title":"npj Antimicrob Resist"},{"key":"11544_CR35","unstructured":"11.EUCAST reading (2024) guide for broth microdilution, version 4.0. https:\/\/www.eucast.org\/ast_of_bacteria\/mic_determination (Scroll down to find the \u2018Broth microdilution - EUCAST reading guide\u2019 link)"},{"key":"11544_CR36","unstructured":"12.EUCAST clinical breakpoints\u2014breakpoints (2024) and guidance. https:\/\/www.eucast.org\/clinical_breakpoints"},{"key":"11544_CR37","unstructured":"13.EUCAST quality control (2024) https:\/\/www.eucast.org\/ast_of_bacteria\/ qualitycontrol"},{"issue":"16","key":"11544_CR38","doi-asserted-by":"publisher","first-page":"6728","DOI":"10.1074\/jbc.m117.778308","volume":"292","author":"TY Hargrove","year":"2017","unstructured":"Hargrove TY, Friggeri L, Wawrzak Z, Qi A, Hoekstra WJ, Schotzinger RJ, Lepesheva GI (2017) Structural analyses of Candida albicans sterol 14\u03b1-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis. J Biol Chem 292(16):6728\u20136743. https:\/\/doi.org\/10.1074\/jbc.m117.778308","journal-title":"J Biol Chem"},{"issue":"2","key":"11544_CR39","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.33263\/BRIAC122.24732488","volume":"12","author":"R Bathula","year":"2021","unstructured":"Bathula R, Muddagoni N, Lanka G, Dasari M, Potlapally S (2021) Glide docking, autodock, binding free energy and drug-likeness studies for prediction of potential inhibitors of cyclin-dependent kinase 14 protein in wnt signaling pathway. Biointerface Res Appl Chem 12(2):2473\u20132488. https:\/\/doi.org\/10.33263\/BRIAC122.24732488","journal-title":"Biointerface Res Appl Chem"},{"issue":"2","key":"11544_CR40","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1006\/jmbi.1994.1017","volume":"235","author":"VN Maiorov","year":"1994","unstructured":"Maiorov VN, Crippen GM (1994) Significance of root-mean-square deviation in comparing three-dimensional structures of globular proteins. J Mol Biol 235(2):625\u2013634. https:\/\/doi.org\/10.1006\/jmbi.1994.1017","journal-title":"J Mol Biol"},{"issue":"14","key":"11544_CR41","doi-asserted-by":"publisher","first-page":"167995","DOI":"10.1016\/j.jmb.2023.167995","volume":"435","author":"SJ Park","year":"2023","unstructured":"Park SJ, Kern N, Brown T, Lee J, Im W (2023) CHARMM-GUI PDB manipulator: various PDB structural modifications for biomolecular modeling and simulation. J Mol Biol 435(14):167995. https:\/\/doi.org\/10.1016\/j.jmb.2023.167995","journal-title":"J Mol Biol"},{"issue":"1\u20133","key":"11544_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0010-4655(95)00042-e","volume":"91","author":"HJ Berendsen","year":"1995","unstructured":"Berendsen HJ, van der Spoel D, van Drunen R (1995) A message-passing parallel molecular dynamics implementation. Comput Phys Commun 91(1\u20133):43\u201356. https:\/\/doi.org\/10.1016\/0010-4655(95)00042-e","journal-title":"Comput Phys Commun"},{"issue":"1","key":"11544_CR43","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7(1):42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"issue":"4","key":"11544_CR44","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski CA (2004) Lead-and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1(4):337\u2013341. https:\/\/doi.org\/10.1016\/j.ddtec.2004.11.007","journal-title":"Drug Discov Today Technol"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11544-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11544-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11544-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:40:57Z","timestamp":1783161657000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11544-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,12]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["11544"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11544-z","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,12]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}